Browse By Person: Jeet, Varinder
|Up a level|
Group by: Item Type | Date
Number of items: 7.
Jeet, Varinder (2014) Therapeutic options for metastatic castration resistant prostate cancer : has the situation improved? In Morais, Christudas (Ed.) Advances in Drug Resistance Research. NOVA Science Publishers, New York USA, pp. 137-154.
Jeet, Varinder, Tevz, Gregor, Lehman, Melanie, Hollier, Brett, & Nelson, Colleen (2014) Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells. Endocrine Related Cancer, 21(5), pp. 723-737.
Jeet, Varinder, Russell, Pamela J., Verma, Nirupama D., & Khatri, Aparajita (2012) Targeting aurora kinases : a novel approach to curb the growth and chemoresistance of androgen refractory prostate cancer. Current Cancer Drug Targets, 12(2), pp. 144-163.
Jongbloed, Sarah L., Kassianos, Andrew J., McDonald, Kylie J., Clark, Georgina J., Ju, Xinsheng, Angel, Catherine E., et al. (2010) Human CD141(+) (BDCA-3)(+) dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. Journal of Experimental Medicine, 207(6), pp. 1247-1260.
Jeet, Varinder, Russell, Pamela, & Khatri, Aparajita (2010) Modeling prostate cancer: a perspective on transgenic mouse models. Cancer and Metastasis Reviews, 29(1), pp. 123-142.
Jeet, Varinder, Ow, Kim, Doherty, Eboney, Curley, Ben, Russell, Pamela, & Khatri, Aparajita (2008) Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer. The Prostate, 68(5), pp. 548-562.
Jeet, Varinder, Hollier, Brett G., & Nelson, Colleen (2014) Targeting the role of YKL40 in metastatic prostate cancer. In 67th Annual Scientific Meeting Urological Society of Australia and New Zealand, 16 - 19 March 2014, Brisbane Convention Exhibition Centre, Brisbane, QLD.